Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 82

Sort by

Sort Order Select

Journal Articles

Reduced Number and Function of Endothelial Progenitor Cells in Patients with Beta Thalassemia Major

Galia Spectre, Pinhas Stark, MD, Arza Steimatzky, MD, Pia Raanani, MD, Dorit Lev, PhD, Ran Kornowski, MD, Idit Pazgal, MD

Blood (2019) 134 (Supplement_1): 2247.

https://doi.org/10.1182/blood-2019-129851

Published: 2019

Journal Articles

Dual Targeting of Mitochondrial Unfolded Protein Response and BCL2 in Acute Myeloid Leukemia

Ran Zhao, BS, Sarah Zarabi, MD, Takenobu Nii, PhD, Ondrej Halgas, PhD, Yulia Jitkova, PhD, Vivian Ruvolo, Lauren Heese, Yuki Nishida, MD PhD, Gautam M. Borthakur, MD, Kensuke Kojima, MD PhD, Martin Stogniew, Wolfgang Oster, MD, Emil Pai, PhD, Eric Davis, MD, Hagop M. Kantarjian, MD, Aaron D Schimmer, MD PhD, Michael Andreeff, MD PhD, Jo Ishizawa, MD PhD

Blood (2019) 134 (Supplement_1): 2562.

https://doi.org/10.1182/blood-2019-127101

Published: 2019

Journal Articles

Disulfiram May Contribute to Apoptosis of Myeloma Cells By Reactivating of Cell Cycle Regulating Gene CDKN2A

Denisa Hrckova Drozdkova, Jan Gursky, PhD, Petra Luzna, Sabina Sevcikova, PhD, Jiri Minarik, MD PhD, Katerina Smesny Trtkova, PhD

Blood (2018) 132 (Supplement 1): 5125.

https://doi.org/10.1182/blood-2018-99-114743

Published: 2018

Journal Articles

Commonly Used Chemotherapy Drugs Differentially Determine Microenvironment-Mediated Protection, Via Mitochondrial Transfer, to B-Precursor Acute Lymphoblastic Leukaemia Cells

Richard J Burt, MBBS, Aditi Dey, PhD, Kenton Cheuk Yan Ng, BSc, Erik Sahai, PhD, Adele K Fielding, MBBS, PhD FRCP, FRCPath

Blood (2018) 132 (Supplement 1): 2690.

https://doi.org/10.1182/blood-2018-99-113370

Published: 2018

Journal Articles

Bone Marrow Mesenchymal Stromal Cells Transfer Their Mitochondria to Acute Myeloid Leukaemia Blasts to Support Their Proliferation and Survival

Christopher Marlein, BSc, Lyubov Zaitseva, BSc, PhD, Rachel E Piddock, BSc, Stephen Robinson, BSc, PhD, Dylan R Edwards, BSc, PhD, Manar S Shafat, MSc, Kristian M Bowles, MBBS, PhD, Stuart A Rushworth, Ph DBSc

Blood (2016) 128 (22): 772.

https://doi.org/10.1182/blood.V128.22.772.772

Published: 2016

Journal Articles

Overexpression of HIF-1α in Mesenchymal Stem Cells Contributes to Repairing Hypoxic-Ischemic Brain Damage in Rats

Qin Yu, Deju Lin, Liping Zhou, Biao Wang, Lizhen Liu, Chuanqin Hu, Fengjing Huang, Lixia Jiang

Blood (2016) 128 (22): 5067.

https://doi.org/10.1182/blood.V128.22.5067.5067

Published: 2016

Journal Articles

Chemosensitizing Effect of Fenretinide-Induced NF-κb Inhibition in AML Therapy

Ranran Zhang, MD, Wei Fenggui, MD, Ru Chen, MD, Ming Liang, MD, Liping Wu, MD, Hui Zhang, MD, PhD, Fuxiong Chen, MD

Blood (2016) 128 (22): 1580.

https://doi.org/10.1182/blood.V128.22.1580.1580

Published: 2016

Journal Articles

Fanconi Anemia Pathway Suppression of R Loops Is a Mechanism of Maintenance of Genomic Stability

Gary Kupfer, MD

Blood (2015) 126 (23): 1216.

https://doi.org/10.1182/blood.V126.23.1216.1216

Published: 2015

Journal Articles

Evaluation of Anti-Neoplastic Effects of a New Hemostatic Agent Ankaferd Blood Stopper on Myeloma Cell Line and Plasmocytoma Development in Balb/c Mice: Results of the First in Vitro and in Vivo Study

Ferit Avcu, MD, Mustafa Guner, Int Dr, Muammer Misirci, Int Dr, Pinar Elci, DDS, Mukerrem Safali, MD, Hakan Goker, MD, Ibrahim Celalettin Haznedaroglu, MD

Blood (2014) 124 (21): 5728.

https://doi.org/10.1182/blood.V124.21.5728.5728

Published: 2014

Journal Articles

Maintenance of Respiration Capacity Is an Early Predictor of Drug Resistance in Cancer Cells

Cornelia A Brendel, MD, Katharina Henkenius, Melanie Maerken, Tom Kaiser, Larissa Greif, Stephan Metzelder, MD, Miriam Rehberger, Andreas Neubauer, MD

Blood (2014) 124 (21): 2157.

https://doi.org/10.1182/blood.V124.21.2157.2157

Published: 2014

Journal Articles

The Role of FcγRIIa and TGF-β1/KLF6 Pathway in Platelet's Promoting Hepatocellular Carcinoma Cells Growth

Ao-Di He, Ming-Lu Liang, Gang Liu, Xing-Wen Da, Guang-Qiang Yao, Wen Xie, Ji-Zhou Xiang, Cunji Gao, MD PhD, Zhang-Yin Ming, MD PhD

Blood (2014) 124 (21): 1429.

https://doi.org/10.1182/blood.V124.21.1429.1429

Published: 2014

Journal Articles

Targeting Lon Protease Activity Promotes Growth Inhibition and Apoptosis in Acute Myeloid Leukemia Cell Lines

Serena De Matteis, BS, Silvia Carloni, BS, Roberta Napolitano, BS, Michele Zanoni, BS, Lara Gibellini, BS PhD, Alessandro Lucchesi, MD, Andrea Cossarizza, MD, Giovanni Martinelli, MD

Blood (2014) 124 (21): 5130.

https://doi.org/10.1182/blood.V124.21.5130.5130

Published: 2014

Journal Articles

MLL Rearrangements in Childhood Acute Lymphoblastic Leukemia: Clinical and Genetic Features of a Distinct Disease Entity

Maria Ampatzidou, MD, Stephanos I. Papadhimitriou, MD PhD, Loizos Petrikkos, MD, Dimitrios Pavlidis, Konstantinos Tsitsikas, Vassilios Papadakis, MD PhD, George Paterakis, MD PhD, Sophia Polychronopoulou, MD PhD

Blood (2014) 124 (21): 5355.

https://doi.org/10.1182/blood.V124.21.5355.5355

Published: 2014

Journal Articles

MNK1 Inhibitor CGP57380 Overcomes the Activation of eIF4E Induced By mTORC1 Inhibitor: The Mechanism of Synergic Killing on T-ALL Cells

XianBo Huang, PhD, Wei He, MS, Jie Jin, MD, Wenbin Qian, MD

Blood (2014) 124 (21): 5215.

https://doi.org/10.1182/blood.V124.21.5215.5215

Published: 2014

Journal Articles

MEK1/2 Inhibition By MEK162 Is Effective Against Chronic Lymphocytic Leukaemia Cells Under Conditions That Mimic Stimulation of B-Cell Receptor-Mediated Signaling

Kyle Crassini, MBBS,BSc, William S Stevenson, MBBS, PhD, Stephen P. Mulligan, MBBS (Hons), PhD, FRACP, FRCPA, Oliver Giles Best, PhDBSc

Blood (2014) 124 (21): 3330.

https://doi.org/10.1182/blood.V124.21.3330.3330

Published: 2014

Journal Articles

Inhibition of Fatty Acid Oxidation with Avocatin B Selectively Targets AML Cells and Leukemia Stem Cells

Eric A Lee, Leonard Angka, Sarah-Grace Rota, Thomas Hanlon, Rose Hurren, Xiao Ming Wang, Marcela Gronda, MSc, Dannie Bernard, Mark D. Minden, MD PhD, Andrew Mitchell, Andrea Edginton, PhD, Shrivani Sriskanthadevan, PhD, Alessandro Datti, PhD, Jeff Wrana, PhD, Jamie W Joseph, PhD, Joe Quadrilatero, PhD, Aaron D. Schimmer, MD PhD, Paul A Spagnuolo, PhD

Blood (2014) 124 (21): 268.

https://doi.org/10.1182/blood.V124.21.268.268

Published: 2014

Journal Articles

The Survivin Suppressant YM155 (Sepantronium Bromide) Has Potent Pre-Clinical Activity Against Pediatric Acute Myeloid Leukemia

Erica B. Little, BSc, BCApSc, MSc, Amanda M. Smith, BBMSc (Hons), Andjelija Zivanovic, BPharm (Hons), MSc, Alfred K.S. Liu, BSc, Shannon Waldron, BAppSc, Wendy J. Ingram, BSc (Hons), PhD, Andrew R. Hallahan, MBBS, FRACP, Andrew S. Moore, MBBS, FRACP, PhD

Blood (2013) 122 (21): 3957.

https://doi.org/10.1182/blood.V122.21.3957.3957

Published: 2013

Journal Articles

2′-Deoxy-5-Azacytidine Enhances Cytotoxic Effect Of Other Anti-Leukemic Agents Synergistically In Acute Lymphoblastic Leukemia Cell Line

Kimiyoshi Sakaguchi, MD, Hiroyoshi Takahashi

Blood (2013) 122 (21): 5564.

https://doi.org/10.1182/blood.V122.21.5564.5564

Published: 2013

Journal Articles

Antitumor Effect Of Sepantronium Bromide (YM155), a Survivin Suppressant, In Combination With Bendamustine and Rituximab In Diffuse Large B-Cell Lymphoma

Naoki Kaneko, Keisuke Mitsuoka, Nobuaki Amino, Kentaro Yamanaka, Aya Kita, Masamichi Mori, Miyoshi Sosuke, Sadao Kuromitsu

Blood (2013) 122 (21): 3073.

https://doi.org/10.1182/blood.V122.21.3073.3073

Published: 2013

Journal Articles

Combination Therapy In Mast Cell Neoplasms: Co-Targeting KIT and NFAT Signaling Pathways

Alison Macleod, Janice Patterson, Carol Beadling, PhD, Diana Griffith, Ajia Town, Arin McKinley, Michael C. Heinrich, MD

Blood (2013) 122 (21): 4105.

https://doi.org/10.1182/blood.V122.21.4105.4105

Published: 2013

NARROW

Reduced Number and Function of Endothelial Progenitor Cells in Patients with Beta Thalassemia Major

Dual Targeting of Mitochondrial Unfolded Protein Response and BCL2 in Acute Myeloid Leukemia

Disulfiram May Contribute to Apoptosis of Myeloma Cells By Reactivating of Cell Cycle Regulating Gene CDKN2A

Commonly Used Chemotherapy Drugs Differentially Determine Microenvironment-Mediated Protection, Via Mitochondrial Transfer, to B-Precursor Acute Lymphoblastic Leukaemia Cells

Bone Marrow Mesenchymal Stromal Cells Transfer Their Mitochondria to Acute Myeloid Leukaemia Blasts to Support Their Proliferation and Survival

Overexpression of HIF-1α in Mesenchymal Stem Cells Contributes to Repairing Hypoxic-Ischemic Brain Damage in Rats

Chemosensitizing Effect of Fenretinide-Induced NF-κb Inhibition in AML Therapy

Fanconi Anemia Pathway Suppression of R Loops Is a Mechanism of Maintenance of Genomic Stability

Evaluation of Anti-Neoplastic Effects of a New Hemostatic Agent Ankaferd Blood Stopper on Myeloma Cell Line and Plasmocytoma Development in Balb/c Mice: Results of the First in Vitro and in Vivo Study

Maintenance of Respiration Capacity Is an Early Predictor of Drug Resistance in Cancer Cells

The Role of FcγRIIa and TGF-β1/KLF6 Pathway in Platelet's Promoting Hepatocellular Carcinoma Cells Growth

Targeting Lon Protease Activity Promotes Growth Inhibition and Apoptosis in Acute Myeloid Leukemia Cell Lines

MLL Rearrangements in Childhood Acute Lymphoblastic Leukemia: Clinical and Genetic Features of a Distinct Disease Entity

MNK1 Inhibitor CGP57380 Overcomes the Activation of eIF4E Induced By mTORC1 Inhibitor: The Mechanism of Synergic Killing on T-ALL Cells

MEK1/2 Inhibition By MEK162 Is Effective Against Chronic Lymphocytic Leukaemia Cells Under Conditions That Mimic Stimulation of B-Cell Receptor-Mediated Signaling

Inhibition of Fatty Acid Oxidation with Avocatin B Selectively Targets AML Cells and Leukemia Stem Cells

The Survivin Suppressant YM155 (Sepantronium Bromide) Has Potent Pre-Clinical Activity Against Pediatric Acute Myeloid Leukemia

2′-Deoxy-5-Azacytidine Enhances Cytotoxic Effect Of Other Anti-Leukemic Agents Synergistically In Acute Lymphoblastic Leukemia Cell Line

Antitumor Effect Of Sepantronium Bromide (YM155), a Survivin Suppressant, In Combination With Bendamustine and Rituximab In Diffuse Large B-Cell Lymphoma

Combination Therapy In Mast Cell Neoplasms: Co-Targeting KIT and NFAT Signaling Pathways

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only